Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and Validation of JAM-A as a Novel Prognostic and Immune Factor in Human Tumors

26 Jun 2024

Abstract excerpt

Junctional adhesion molecule-A (JAM-A), also known as F11 receptor (F11R), is a transmembrane glycoprotein that is involved in various biological processes, including cancer initiation and progression. However, the functional characteristics and significance of JAM-A in pan-cancer remain unexplored. In this study, we used multiple databases to gain a comprehensive understanding of JAM-A in human cancers. JAM-A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cell Adhesion Molecules Research
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39061997
DOI: 10.3390/biomedicines12071423

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and Validation of JAM-A as a Novel Prognostic and Immune Factor in Human TumorsPMID 39061997Read ↗

High expression of JAM2 indicates better prognosis and immunotherapy response in breast cancerSemantic proximity Read ↗

Aberrant expression of JAM2 inhibits invasion and migration in lung adenocarcinomaSemantic proximity Read ↗

JAM‐A expression positively correlates with poor prognosis in breast cancer patientsSemantic proximity Read ↗

Targeting Opposing Immunological Roles of the Junctional Adhesion Molecule-A in Autoimmunity and CancerSemantic proximity Read ↗

The Roles of Junctional Adhesion Molecules (JAMs) in Cell MigrationSemantic proximity Read ↗

High-Throughput Flow Cytometry Screening Reveals a Role for Junctional Adhesion Molecule A as a Cancer Stem Cell Maintenance FactorSemantic proximity Read ↗

KIF11 As a Potential Pan‐Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic ResponsesSemantic proximity Read ↗

Cooperative expression of junctional adhesion molecule‐C and ‐B supports growth and invasion of gliomaSemantic proximity Read ↗

Role of Metastasis Suppressor KAI1/CD82 in Different CancersSemantic proximity Read ↗

Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastasis via the TGF-β/Smad signal pathwaySemantic proximity Read ↗

JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cellsSemantic proximity Read ↗

Tight Junction Protein Signaling and Cancer BiologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.